Login / Signup

Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19.

Qingqin TanLingjie HeXiaojun MengWei WangHudan PanWeiguo YinTianchuan ZhuXi HuangHong Shan
Published in: Journal of nanobiotechnology (2021)
Collectively, such macrophage biomimetic nanocarriers based drug delivery system showed favorable anti-inflammation and targeted antiviral effects, which may possess a comprehensive therapeutic value in COVID-19 treatment.
Keyphrases
  • coronavirus disease
  • cancer therapy
  • sars cov
  • drug delivery
  • oxidative stress
  • drug release
  • smoking cessation